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Abstract 23 
The replacement of fish oil (FO) with vegetable oil (VO) in feed formulations reduces 24 
the availability of n-3 long-chain polyunsaturated fatty acids (LC-PUFA) to marine fish 25 
such as gilthead seabream. The aim of this study was to examine compositional and 26 
physiological responses to a dietary gradient of n-3 LC-PUFA. Six isoenergetic and 27 
isonitrogenous diets (D1-D6) were fed to seabream, with the added oil being a blend of 28 
FO and VO to achieve a dietary gradient of n-3 LC-PUFA. Fish were sampled after four 29 
months feeding, to determine biochemical composition, tissue fatty acid concentrations 30 
and lipid metabolic gene expression. The results indicated a disturbance to lipid 31 
metabolism, with fat in the liver increased and fat deposits in the viscera reduced. 32 
Tissue fatty acid profiles were altered towards the fatty acid compositions of the diets. 33 
There was evidence of endogenous modification of dietary PUFA in the liver which 34 
correlated with the expression of fatty acid desaturase 2 (fads2). Expression of sterol 35 
regulatory element-binding protein 1 (srebp1), fads2 and fatty acid synthase increased 36 
in the liver, while peroxisome proliferator-activated receptor alpha 1 pathways appeared 37 
to be supressed by dietary VO in a concentration-dependent manner. The effects in 38 
lipogenic genes appear to become measurable in D1-D3, which agrees with the weight 39 
gain data suggesting that disturbances to energy metabolism and lipogenesis may be 40 
related to performance differences. These findings suggested that suppression of beta-41 
oxidation and stimulation of srebp1-mediated lipogenesis may play a role in 42 
contributing toward steatosis in fish fed n-3 LC-PUFA deficient diets.  43 
  44 
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1. Introduction 45 
Sustainable expansion of aquaculture requires reduction in the use of fishmeal (FM) and 46 
fish oil (FO) in aquafeed formulations (1-4). Both raw materials, particularly FO, are rich 47 
in the two key n-3 (or omega-3) long-chain (≥ C20) polyunsaturated fatty acids (LC-48 
PUFA), eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-49 
3), recognised as essential fatty acids (EFA) for the majority of marine fish species (5). 50 
DHA is an essential component of neural and retinal membranes (6) and both EPA and 51 
DHA are precursors for an extensive range of autocrine signalling molecules (e.g. 52 
eicosanoids, resolvins, protectins, etc.) (7). Dietary deficiency of n-3 LC-PUFA has 53 
impacts on the health (8), metabolism (9, 10) , composition (11, 12) and growth (13) of marine 54 
fish.  55 
Typically, an aquafeed for a given marine fish species contains a combination of 56 
FO to supply essential n-3 LC-PUFA and vegetable oils (VO) that, while devoid of LC-57 
PUFA, supply dietary energy (14, 15). Marine fish lack sufficient activity of the LC-PUFA 58 
biosynthesis pathway to satisfy requirements (5). In terms of fatty acid composition, the 59 
key effects of high inclusion levels of VO are an increase in C18 unsaturated fatty acids 60 
(α-linolenic acid, linoleic acid and oleic acid) in the fish tissues at the expense of LC-61 
PUFA that is reflective of the altered composition of dietary fatty acids (16). With 62 
regards to lipid metabolism, studies have reported that inclusion of dietary VO leads to 63 
reduced fatty acid catabolism and the accumulation of lipid in liver of Atlantic salmon 64 
(Salmo salar) and gilthead seabream, (17-19). Studies examining the influence of VO on 65 
lipid biosynthesis have yielded conflicting results with some reporting increased gene 66 
expression in Atlantic salmon and black seabream (Acanthopagrus schlegelii)  (18, 19) 67 
4 
 
 
and others reporting decreased enzyme activity in gilthead seabream (20) although, in 68 
mammals, EPA has been shown to supress lipogenesis (21).  69 
Lipid homeostasis is maintained in animals through a balance of catabolic and 70 
anabolic processes. Fatty acids and cholesterol can be synthesised de novo by pathways 71 
that are activated by sterol regulatory element binding proteins (Srebp) 1 and 2, 72 
respectively. Srebp are transcription factors involved in energy homeostasis and have 73 
many target genes with examples of those in lipid metabolism including fatty acid 74 
synthase (fas) and fatty acid desaturase 2 (fads2), the latter being key enzymes in the 75 
LC-PUFA biosynthesis pathway (22, 23). Fatty acids are catabolised by the β-oxidation 76 
pathway in either mitochondria or peroxisomes, and expression of genes encoding 77 
proteins involved in these pathways are regulated by, among others, peroxisome 78 
proliferator-activated receptors (Ppar) (24). Upon binding ligands and retinoid X 79 
receptor, Ppars bind to peroxisome proliferator response elements in the promoter 80 
regions of target genes, many of which are involved in β-oxidation, such as carnitine 81 
palmitoyl transferase I (cpt1a) and liver-type fatty acid binding protein (fabp1), both 82 
proteins  involved in the intracellular transport of fatty acids destined for catabolism (24, 83 
25). 84 
Despite recent advances in our knowledge regarding the impacts of dietary VO 85 
some questions remain, for instance, are dietary differences in gene expression 86 
dependent on precise concentrations of dietary nutrients or are genes 87 
activated/deactivated at particular levels of FO substitution? Therefore, the present 88 
study aimed to examine the impact of modern (high lipid, low fish meal) aquafeed 89 
formulations across a gradient of n-3 LC-PUFA, achieved by blending commercially 90 
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available oils (FO, rapeseed oil and palm oil), on the biochemical composition of body 91 
compartments, and fatty acid compositions and gene expression in the liver and mid-92 
intestine of a marine teleost, the gilthead seabream (Sparus aurata). The liver being a 93 
key metabolic tissue in vertebrate metabolism and the mid-intestine being a primary site 94 
of nutrient absorption and processing. 95 
2. Experimental methods 96 
2.1 Fish husbandry and diets 97 
The nutritional trial was carried out at the BioMar Feed Trial Unit (Hirtshals, 98 
Denmark) between April and August 2014. Seabream juveniles of approximately 3 g 99 
were purchased from a commercial hatchery (Les Poissons du Soleil, Balaruc-les-Bains, 100 
France) and randomly distributed among 18 x 1 m3 tanks. The tanks were part of a 101 
Recirculation Aquaculture System (RAS) with photoperiod, temperature and salinity 102 
maintained at 12:12 h L:D, 24 °C and 32 ppm, respectively. Initially, the fish were fed 103 
with commercial fry feeds rich in FM and FO until they reached ~24 g. After 104 
acclimation, each tank was assigned one of six iso-energetic and iso-nitrogenous diets 105 
for 18 weeks, initially as a 3 mm pellet (8-weeks) and then with a 4.5 mm pellet to the 106 
end of the trial. Fish were fed to satiation twice per day using automatic feeders and 107 
waste feed was collected to accurately measure feed consumption. The six diets were 108 
formulated to deliver specific levels of LC-PUFA by progressively replacing FO with 109 
blends of rapeseed and palm oil, whereas the other dietary ingredients were selected to 110 
meet the known nutrient requirements of seabream (26) (Table 1). Diets were produced 111 
by extrusion at the BioMar Tech-Centre (Brande, Denmark). The experimental diets 112 
were numbered to reflect the VO/FO inclusion so that diet D1 contained the VO blend 113 
as sole exogenously added oil source, diet D6 contained only FO, and diets D2 - D5 114 
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contained graded levels of VO and FO as described in Table 1. The fatty acids that 115 
increased with dietary FO were: 16:1n-7, 24:1n-9, 20:3n-6, 20:4n-6, 20:4n-3, 20:5n-3, 116 
22:5n-3 and 22:6n-3, while 20:0, 22:0, 18:1n-9, 18:2n-6 and 18:3n-3 increased with 117 
dietary VO (Table 2).  118 
Experimental animals were maintained under the current European legislation on 119 
handling experimental animals. In addition, all research performed by the Institute of 120 
Aquaculture, University of Stirling (UoS) is subject to thorough ethical review carried 121 
out by the UoS Animal Welfare and Ethical Review Board (AWERB) prior to any work 122 
being approved. This involves all projects, irrespective of where they are carried out, to 123 
be submitted to AWERB for approval using detailed Ethical Approval forms that 124 
require all aspects of the experimentation to be described including all animal health 125 
and welfare issues as well as other ethical considerations. The present research was 126 
assessed by the UoS AWERB and passed the ethical review process of the University of 127 
Stirling. 128 
2.2 Sampling 129 
Fish were sampled at the initiation of the trial and at termination after being 130 
euthanised with a lethal dose of benzocaine (Centrovet, Kalagin, Santiago, Brazil). Fish 131 
were not fed the day before sampling. Five whole fish and three eviscerated carcasses, 132 
liver and viscera (the entire contents of the body cavity minus the liver) were sampled 133 
from each tank for compositional analysis. Three fish per tank were also sampled for 134 
gene expression and fatty acid composition taking samples of liver and mid-intestine. 135 
Samples for RNA analysis were incubated with 1 mL RNAlater® at 4 °C for 24h 136 
(Sigma-Aldrich, UK) before storage at -70°C, while samples for fatty acid analysis were 137 
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immediately frozen and stored at -20 °C before shipment on dry ice to the Institute of 138 
Aquaculture, University of Stirling. 139 
2.3 Proximate composition 140 
Feed samples were ground prior to analyses. Whole fish, carcass and viscera 141 
samples were homogenised in a blender (Waring Laboratory Science, Winsted, CT, 142 
USA) to produce pates. Proximate compositions of feeds and fish were determined 143 
according to standard procedures (27). Moisture contents were obtained after drying in an 144 
oven at 110 °C for 24 h and ash content determined after incineration at 600 °C for 16 h. 145 
Crude protein content was measured by determining nitrogen content (N × 6.25) using 146 
automated Kjeldahl analysis (Tecator Kjeltec Auto 1030 analyser, Foss, Warrington, 147 
U.K) and total lipid content determined as described below.  148 
2.4 Lipid extraction  149 
Total lipid for fatty acid analyses was extracted from seabream tissues according 150 
to Folch et al. (28). Briefly, liver and mid-intestine samples (~ 0.5 g) were homogenised 151 
in 20 mL chloroform/methanol (2:1, v/v) and incubated for 1 h on ice. Subsequently, 5 152 
mL of 0.88 % KCl (w/v) was added, samples were vortexed and centrifuged at 400 g to 153 
separate organic and aqueous fractions. The aqueous fraction was discarded and the 154 
organic layer (infranatant) was then filtered (Whatman No. 1) and solvent evaporated 155 
under a stream of oxygen-free nitrogen. After desiccation in vaccuo overnight, lipid 156 
content was determined gravimetrically. Total lipid samples were stored at 10 mg ml-1 157 
in chloroform/methanol (2:1, v/v) containing 0.01 % (w/v) butylated hydroxytoluene 158 
(BHT) as antioxidant. 159 
2.5 Fatty acid analysis 160 
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Fatty acids were quantified by gas-liquid chromatography (GC) after preparation 161 
of fatty acid methyl esters (FAME) by acid-catalysed transesterification of total lipid 162 
(29). Briefly, 1 mg of total lipid and 0.1 mg of heptadecanoic acid (17:0) as internal 163 
standard were incubated with 1 ml toluene and 2 ml 1 % sulphuric acid in methanol 164 
(v/v) for 16 h at 50 °C. FAME were extracted and purified by thin-layer-165 
chromatography as described by Tocher and Harvie (30) and resuspended in isohexane 166 
before GC analysis using a Fisons GC-8160 (Thermo Scientific, Milan, Italy) equipped 167 
with a 30 m × 0.32 mm i.d. × 0.25 µm ZB-wax column (Phenomenex, Cheshire, UK), 168 
on-column injector and a flame ionisation detector. Data were collected and processed 169 
using Chromcard for Windows (version 2.01; Thermoquest Italia S.p.A., Milan, Italy). 170 
FAME were identified by comparison to known standards (Supelco 37-FAME mix; 171 
Sigma-Aldrich Ltd., Poole, UK) and published data (30). Fatty acid contents were 172 
expressed as mg g-1 of tissue and estimated using the response of the internal standard. 173 
The coefficient of variation estimated using mg DHA g-1 over a subset of 20 samples 174 
was 2.80 ± 2.51 %. 175 
2.6 RNA extraction 176 
Total RNA was extracted from ~100 mg of liver and mid-intestine by 177 
homogenisation in 1 mL of TriReagent (Sigma-Aldrich, Dorset, UK) using a Mini-178 
Beadbeater 24 (Biospec, Bartlesville, Oklahoma, USA). Phase separation was achieved 179 
by the addition of 100 µl of 1-bromo-3-chloropropane (BCP, Sigma) and centrifugation 180 
at 20,000 g. Subsequently 400 µl of the supernatant were recovered and RNA 181 
precipitated by the addition of 200 µl isopropanol (Fisher, UK) and 200 µl RNA 182 
precipitation solution (1.2 M sodium chloride and 0.8 M sodium citrate sesquihydrate) 183 
followed by centrifugation at 20,000 g. The resulting pellet was washed twice with 75 184 
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% ethanol, air-dried and resuspended in 50 µl nuclease-free water. The concentration 185 
and quality were verified spectrophotometrically (NanoDrop ND-1000, 186 
Spectrophotometer, Sussex, U.K.) and by agarose gel electrophoresis to visualise the 187 
presence of 18S and 28S ribosomal subunits. Extracts were stored at -70 °C until cDNA 188 
synthesis. 189 
2.7 cDNA synthesis 190 
Reverse transcription was performed according to the kit manufacturer’s protocol 191 
(High Capacity Reverse Transcription kit, Applied Biosystems, Warrington, UK). A no 192 
template control (NTC) reaction and reverse transcriptase-free reactions were prepared 193 
as blank and negative controls. Each 20 µl reaction included: 10x reverse transcription 194 
buffer (2 µl), 100 mM dNTP mix (0.8 µl), 10 µM random primers (1.5 µl), 10 µM oligo 195 
dT primers (0.5 µl), reverse transcriptase (1.0 µl), 2 µg of total RNA as template and 196 
nuclease-free water to make up the volume. RNA was denatured at 95 °C for 10 min 197 
prior to addition of master mix containing all other reagents. Reverse transcription was 198 
performed on a Biometra Thermocycler (Analytik Jena, Goettingen, Germany) using the 199 
following program: 25 °C for 10 min, 37 °C for 120 min, 85 °C for 5 min and then 200 
terminated at 4 °C. A pool of cDNA samples was created for serial dilutions, calibrator 201 
samples and primer validations. Samples of cDNA were diluted 20-fold with nuclease-202 
free water as template for qPCR, and stored at -20 °C.  203 
2.8 Gene expression analysis 204 
Gene expression was determined for candidate genes involved in key pathways by 205 
quantitative real time PCR (qPCR). Primers for qPCR were designed using Primer3 206 
through the NCBI database’s “Primer-BLAST” against known gene sequences 207 
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including sequences from the S. aurata expressed sequence tag (EST) NCBI database 208 
that were confirmed to be the gene of interest by BLAST searches. Primer sequences for 209 
genes in the present study are given in Table 3. Primers were tested to confirm that they 210 
functioned optimally at annealing temperatures of 60 °C and that a single amplicon of 211 
appropriate length was visualised on agarose gel. A serial dilution of the cDNA pool 212 
was analysed by qPCR (Luminaris Color HiGreen qPCR Master Mix, Thermo 213 
Scientific, Hemel Hempstead, UK) to determine primer efficiency (rejected at < 1.85). 214 
Duplicated qPCR reactions were carried out on 96-well plates, each reaction contained: 215 
Luminaris Color HiGreen (10 µl), 10 µM primers (1 µl each), 1/20 diluted cDNA 216 
sample (5 µl and 2 µl for target and reference genes, respectively) and nuclease-free 217 
water up to 20 µl. As there were 54 samples per tissue (6 treatments, n = 9) two plates 218 
were run per gene with treatments equally represented on both plates, a 1/20 dilution of 219 
the cDNA pool was used as a calibrator and a serial dilution included on one plate. A 220 
single master mix was used for all the reactions required per gene and both plates were 221 
run consecutively on a Biometra TOptical Thermocycler (Analytik Jena). The 222 
thermocycling program was 50 °C for 2 min, 95 °C for 10 min, 35 cycles of 95 °C for 223 
15 s (denaturation), 60 °C for 30 s (annealing) and 72 °C (extension) for 30 s, followed 224 
by a melting curve to check for non-specific products. Data were acquired through the 225 
software package qPCRsoft 3.1 (Analytik Jena) and calculations for sample expression 226 
ratios were carried out according to Pfaffl (31): 227 
𝐸𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑟𝑎𝑡𝑖𝑜 = !(!"#)!"(!"#$%&)!(!"#)!"(!"#$%&) ÷ !(!"#)!"(!"#$%&"'(&)!(!"#)!"(!"#$%&"'(&)  228 
 229 
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where E is the determined efficiency, ref is the geometric mean of four reference genes, 230 
goi is the gene of interest and Ct is the threshold cycle. The genes of interest were 231 
normalised to the geometric mean of four reference genes, elongation factor 1α (ef1α), 232 
beta-actin (β-act), alpha-tubulin (tuba1α) and ribosomal protein P0 (rplp0), whose 233 
expression was not influenced by dietary treatment. Gene expression data are presented 234 
as log2 expression ratios (32) of genes related to lipid metabolism: srebp1 (sterol 235 
regulatory element binding factor 1), srebp2 (sterol regulatory element binding factor 236 
2), pparα1 (peroxisome-proliferator activated receptor alpha 1), fas (fatty acid 237 
synthase), fads2 (fatty acid desaturase 2), cpt1α (carnitine palmitoyltransferase I) and 238 
fabp1 (fatty acid binding protein 1) and elovl5 (elongation of very long chain fatty acid 239 
5 protein). The average intra assay coefficient of variation was 0.44 ± 0.12 % at the 240 
level of quantification cycle (Cq). 241 
2.9 Statistical analysis  242 
Final weights, specific growth rate (SGR), proximate composition and tissue fatty 243 
acids were analysed by between groups ANOVA, rejecting null hypotheses at P < 0.05. 244 
Absence of within treatment effects (i.e. tank effects) were first confirmed using tank as 245 
a nested variable in the ANOVA formula. F-tests were verified by Bartlett’s test and 246 
Shapiro-Wilk for variance homogeneity and distribution. 247 
Three individuals from each tank (9 per treatment) were randomly sampled giving 54 248 
fish in total, this is the minimum number of fish to detect medium effect sizes (f 2 = 249 
0.15; power = 0.8) by ordinary least squares regression. Proximate composition data 250 
were analysed using linear regression to identify the existence of trends across the 251 
experimental diets. Trends were reported as significant if the slope was significantly 252 
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different (P < 0.05) to 0. For fatty acid profiles of  tissues (n = 54) the first step of 253 
analysis was to reduce the dimensions of the data by principal component analysis 254 
(PCA), which enabled the identification of fatty acids that were correlated with each 255 
other and that should be analysed further. The level of dietary FO was supplied as a 256 
supplementary variable to PCA. Fatty acids with several no detects (effectively zero) 257 
were removed from the data set, because zero values are problematic with PCA 258 
analysis, and the C20 and C22 monounsaturated fatty acids were combined into two 259 
single variables (20:1 and 22:1, respectively) as these peaks do not always separate in 260 
the GC analysis. Further analyses of selected fatty acids were performed using 261 
regression of the tissue fatty acid concentration as a function of the diet fatty acid 262 
concentration. Tissue fatty acid levels were regressed with absolute data (mg g-1 tissue). 263 
Where a range was reported, this was derived from the fitted values of the model 264 
applied to the data, not the mean values reported in the Supplementary tables. Where 265 
appropriate, percentage data (% of total fatty acids) were used to support the analyses. 266 
When a fatty acid did not have a dietary component it was regressed against dietary VO, 267 
for instance the fatty acid 18:2n-9, and the expression of genes. Analyses and plots were 268 
produced in the statistical package R (33) (version 3.1.3, Vienna, Austria). PCA were 269 
performed using the FactoMineR package (34) and regression diagnostics using the Car 270 
package (35). 271 
3. Results 272 
3.1 Growth rates and proximate composition of gilthead seabream 273 
After feeding the experiment diets for 18 weeks mean weights ranged between 274 
200 - 250 g and SGR’s between 1.64 – 1.81, with significant differences (P < 0.001) 275 
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between dietary groups that showed increasing the dietary VO content beyond the level 276 
of that in diet D4 led to reduced growth (Table 4). 277 
Significant effects of diet on proximate compositions of gilthead seabream were 278 
observed in liver, mid-intestine and viscera. In liver and mid-intestine, total lipid 279 
contents increased from 18.6 – 31.8 % diet (R2 = 67.8, P < 0.001) and 8.6 – 13.9 % (R2 280 
= 23.9, P < 0.001), respectively, as dietary VO increased from 0 – 15.6 % of diet. In 281 
viscera (minus liver), total lipid content decreased from 53.5 – 45.2 % (R2 = 24.0, P < 282 
0.001) as dietary VO increased in the diet. The lipid contents of whole fish and carcass 283 
were unaffected by dietary treatment (P > 0.05). Protein and ash contents were not 284 
affected in any body compartment examined in the present study (P > 0.05). A summary 285 
of these data is presented in Supplementary table S1. 286 
3.2 Fatty acid composition of liver and mid-intestine 287 
Fatty acid profiles of total lipid of two major lipid metabolic sites, namely liver 288 
and mid-intestine, were determined and further analysed by PCA. In both the liver and 289 
mid-intestine the first principal component (PC1) was correlated to dietary FO and 290 
explained 57.5 % and 60.1 % of the variance in fatty acid compositions, respectively 291 
(Figs. 1 and 2). The fatty acids associated with FO, namely 14:0, 16:1n-7, 20:4n-3, 292 
20:5n-3, 22:5n-3 and 22:6n-3, had positive correlations to PC1, and those associated 293 
with VO, specifically 18:1n-9, 18:2n-6 and 18:3n-3, a negative correlation to PC1 in 294 
liver and mid-intestine Thus, PC1 separated the fatty acid profiles according to diet, D1 295 
had low values and D6 had high values for PC1. PC2 accounted for 15.3 % and 15.5 % 296 
of the variance in liver and mid-intestine fatty acid profiles, respectively. The 297 
contributions of the fatty acids towards PC2, which separated the profiles vertically in 298 
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Figs. 1 and 2, differed between liver and mid-intestine. In liver, 20:2n-6 and 20:1 had a 299 
positive influence on PC2, and 18:2n-9, 20:2n-9, 18:3n-6, 20:3n-6 a negative influence, 300 
with these fatty acids thus being important to separate individual fatty acid profiles once 301 
the variability due to PC1 (diet) had been accounted for. In the case of mid-intestine 302 
samples, 18:0, 20:0 and 22:0 had a positive influence, and 18:1n-7 a negative influence 303 
on PC2 while 18:2n-9 and 20:2n-9 were not detected, again it can be interpreted that 304 
these are the fatty acids that vary the most between individual fatty acid profiles once 305 
the effect of PC1 had been removed. It was also apparent from biplots that there was 306 
considerable overlap between the fatty acid profiles of liver and mid-intestine of fish 307 
consuming diets D1 - D4, although fatty acid profiles from individuals fed on diets 308 
containing the highest inclusion levels of FO (D5 and D6) formed clearly separated 309 
groups (panels A in Figs. 1 and 2). PCA indicated that the n-3 LC-PUFA (20:3n-3, 310 
20:4n-3, EPA, DPA and DHA) were all correlated with each other in both liver and 311 
mid-intestine and therefore these fatty acids were summed as a single variable reflecting 312 
their origin from FO. Absolute levels of tissue n-3 LC-PUFA were strongly related to 313 
dietary n-3 LC-PUFA in liver (R2 = 0.75, P < 0.001) and mid-intestine (R2 = 0.87, P < 314 
0.001) (Fig. 3). Absolute levels of monounsaturates (MUFA) responded positively to 315 
dietary MUFA in liver (R2 = 0.57, P < 0.001) and mid-intestine (R2 = 0.76, P < 0.001) 316 
(Fig. 4). Contents of MUFA in liver were typically 75 - 175 mg g-1 in fish fed diets D1 - 317 
D4, and < 50 mg g-1 in fish consuming the FO diet (D6). High variability is evident in 318 
MUFA levels with the major contributing factor being variation in the total lipid content 319 
of the tissues. Two fatty acids, namely 18:2n-9 and 20:2n-9, were identified in liver in 320 
spite of their absence in diets and mid-intestine, so they were plotted against dietary 321 
VO. Levels of 18:2n-9 increased with the dietary VO (R2 = 0.81, P < 0.001) (Fig. 5A). 322 
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The level of 18:2n-9 was correlated (R2 = 0.41, r = 0.64, P < 0.001) to the log2 323 
expression of fads2 (Fig. 5B), the latter data requiring to be transformed to satisfy the 324 
assumptions of Pearson’s correlation. Dietary levels of saturates were relatively stable 325 
across the experimental diets (32 - 36 g kg-1). Despite this low range, livers of fish fed 326 
diet D1 (VO rich) contained 50 - 70 mg g-1 saturates and those of fish fed diet D6 (FO 327 
rich) ranged between 10 - 40 mg g-1, and there was a significant relationship with 328 
dietary saturates (R2 = 0.27, P < 0.001) (data not shown). Examination of percentage 329 
data indicated that absolute levels of saturates was mainly associated with the increasing 330 
lipid level of the liver, lower levels of saturates were observed in the mid-intestine (15 – 331 
35 mg g-1). Quantitatively, palmitic acid was the dominant saturated fatty acid in both 332 
tissues and only 14:0 increased with dietary FO. Liver and mid-intestine fatty acid data 333 
are summarised in Supplementary Tables, S2 and S3, respectively, where they are 334 
analysed by ANOVA, with the results being in agreement with those reported above. 335 
3.3 Gene expression 336 
Genes representing lipid metabolic pathways were assayed by qPCR, and the 337 
expression of target genes plotted against dietary VO and, although variability (R2 = 19 338 
– 52 %), between individuals was high, significant trends showed that the diets had an 339 
impact on the regulation of lipid metabolism. Subtle, negative trends were found in the 340 
liver between dietary VO and the expression of pparα1 (R2 = 0.32, P < 0.001) and its 341 
target genes cpt1α (R2 = 0.26, P < 0.001) and fabp1 (R2 = 0.19, P < 0.001) (Fig. 6). The 342 
highly variable within treatment data indicated that diet is not the sole source of this 343 
variation in the expression of these genes. The level of variation in the mid-intestine 344 
prevented the application of suitable models to the data. In the liver, positive trends, 345 
fitted with quadratic functions were found between VO and srebp1 (R2 = 0.37, P < 346 
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0.001) and its target genes fas (R2 = 0.42, P < 0.001) and fads2 (R2 = 0.52, P < 0.001) 347 
(Fig. 7). Effects of VO on the expression of srebp2 and elovl5 in liver were not detected 348 
(data not shown). However, in mid-intestine, the effect on srebp1 expression was not as 349 
strong and linear (R2 = 0.23, P < 0.001), but srebp2 showed a strong up-regulation in 350 
fish fed diets D1 and D2 (R2 = 0.49, P < 0.001) and elovl5 was responsive to dietary VO 351 
(R2 = 0.26, P < 0.001) (Fig. 8). Effects of VO on the expression of fads2 were not 352 
detected in mid-intestine (data not shown).  353 
4. Discussion 354 
Replacement of FO by alternative oils in aquafeeds has been an extensively 355 
investigated research topic over the last two decades (16). The most common FO 356 
alternatives are VOs, for example rapeseed oil or soya bean oil, which are devoid of 357 
essential LC-PUFA and, consequently, their use has important implications, not only on 358 
the nutritional value of the product for consumers (36-38), but also effects on metabolism 359 
and fish health (1). We employed a dietary gradient of VO to span the EFA requirements 360 
reported for a commercially relevant teleost, the gilthead seabream (26) and show how 361 
this gradient modifies the composition and the expression of lipid metabolic and 362 
regulatory genes in gilthead seabream juveniles. 363 
Fish consuming diets D4-D6 (LC-PUFA: 1.20-3.54 % of diet) gained significantly 364 
more weight than the other dietary groups, a likely result that these diets were supplied 365 
EPA and DHA in excess of the nutrient requirement. The results of the present study 366 
show that dietary provision of n-3 LC-PUFA below the reported EFA requirement, 0.9 367 
% EPA+DHA dry weight, for gilthead seabream (15) led to alterations in lipid 368 
metabolism as indicated by increased lipid content in liver and decreased lipid in 369 
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viscera, the latter being regarded as the normal lipid storage site in this species (39). 370 
These results were in agreement with previous studies regarding increased hepatic lipid 371 
content as a result of dietary deficiency of EPA and DHA in gilthead seabream (13, 17, 40) 372 
and other fish species (1, 41). Interestingly, increased lipid contents in liver have been also 373 
described when dietary lipid was increased to boost the energy content of the diet (42). 374 
The range of values for hepatic total lipid was 17 - 32 % (wet wt) and these were higher 375 
than those reported previously, 15 - 25 % (wet wt), in gilthead seabream fed graded 376 
levels of soya bean oil (13). This may be due to the larger size of the fish in the present 377 
trial (24-230g) whereas the previous study used fry (1.2-12.4g), the longer feeding 378 
period of four months in the present study, or the higher crude lipid levels in the diets. 379 
In the previous study there was a threshold level of soya bean oil (~ 50 % of oil) that 380 
increased hepatic lipid content whereas data in the present study suggested VO 381 
increased hepatic lipid in a concentration-dependant manner (linear increase).  382 
Quantitatively, the main fatty acids driving the increased liver lipid were 18:1n-9 383 
(oleic acid), 18:2n-6 (linoleic acid) and 18:3n-3 (α-linolenic acid), all major constituents 384 
of the VO used in the experimental diets. Such accumulation of dietary fatty acids 385 
observed in liver, occurring as well in mid-intestine, has been commonly reported in FO 386 
replacement studies in gilthead seabream (12, 13, 43). Interestingly, two fatty acids, namely 387 
18:2n-9 and 20:2n-9, were found in the liver, but not mid-intestine, of fish fed VO that 388 
were not present in the diets. The presence of 18:2n-9 is likely to be the result of Δ6 389 
desaturation of 18:1n-9, with 20:2n-9 being the elongation product of 18:2n-9. Fads2 is 390 
typically a Δ6 desaturase in marine teleosts (23) and, although its activity towards 18:1n-391 
9 has not been demonstrated in gilthead seabream (44), it is likely that Fads2 activity was 392 
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responsible for observed production of 18:2n-9 in liver. Additional data in the form of 393 
enzyme protein levels or activity assays could lend support to this conclusion. Indeed, 394 
this is consistent with increased expression of fads2 in liver of fish fed high VO diets 395 
and n-3 LC-PUFA deficient diets, a regulatory mechanism often reported in literature 396 
not only on desaturases, as observed herein, but also elongases such as elovl5 (19). 397 
Interestingly, an up-regulation of hepatic elovl5 was not observed, that would support 398 
the production of 20:2n-9 mentioned above. Instead, a moderate but detectable increase 399 
in elovl5 expression was observed in the mid-intestine with dietary VO, in agreement 400 
with previous studies on seabream (45), and it is likely that this decrease is a response to 401 
declining availability of n-3 LC-PUFA. Hepatic fads2 expression was variable between 402 
individual fish fed diets with high VO inclusion (D1 - D4). The PCA analysis showed 403 
that this was also the case for the fatty acid profiles of fish consuming these diets and 404 
that 18:2n-9 and 20:2n-9 were important fatty acids in driving this variability. 405 
Furthermore, the level of 18:2n-9 was strongly correlated to the level of fads2 406 
transcripts in the liver. It may be possible to exploit this individual variability in 407 
response to VO to select seabream that are better adapted to diets that are rich in VO, as 408 
has been described previously in Atlantic salmon (18). The fatty acids, 18:2n-9 and 409 
20:2n-9, are metabolites of 18:1n-9 derived from its metabolism via the LC-PUFA 410 
biosynthesis pathway. Marine fish are able to perform the first two steps, delta-6 411 
desaturation (fads2) and elongation (elovl5), but are unable to perform the subsequent 412 
step of the pathway due to the absence of an active delta-5 desaturase (46). The above 413 
result shows that the delta-6 in seabream can operate on 18:1n-9. 414 
In addition to the distinctive patterns of fads2 and elovl5 expression described 415 
above, the regulatory mechanisms by which dietary fatty acids modulate metabolic 416 
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responses in liver and mid-intestine appear to differ. In liver, srebp1, but not srebp2, 417 
was increased in gilthead seabream fed diets D1 - D3, with a threshold between diets 418 
D3 and D4, interestingly this at the point where effects on growth were also observed. 419 
In mid-intestine, both srebp1 and srebp2 expression were increased with dietary VO. 420 
Srebp signalling is responsible for maintaining lipid levels in balance and, although 421 
there is some overlap between the functions of Srebp1 and Srebp2, the former is mainly 422 
associated with fatty acid/lipid synthesis, whereas the latter is associated with 423 
cholesterol synthesis in mammals (22, 47, 48) and fish (49). While the up-regulation of 424 
srebp1 has been often associated with increased expression of fads2 in response to VO-425 
rich diets (18, 19, 50), the up-regulation of srebp2 in mid-intestine suggested putative 426 
activation of cholesterol biosynthesis. Cholesterol was added to the experimental diets 427 
to balance the supply of this key nutrient, but VOs are known to contain a range of 428 
phytosterols that may have stimulated upregulation in the mid intestine (25, 51-53).  429 
The fas gene is also regulated by Srebp1 (22) and its product, Fas, is an enzyme 430 
complex responsible for de novo synthesis of saturated fatty acids (54, 55). Despite the 431 
inclusion of 20 % lipid in the diets, the inclusion of VO resulted in up-regulation of fas 432 
in liver. There have been reports of VO increasing fas expression in Atlantic salmon (18) 433 
and black seabream (19). Nevertheless, this is not always supported by measurements of 434 
Fas activity in gilthead seabream fed diets with 80 % of dietary FO replaced with 435 
linseed oil (20) however, in turbot (Scophthalmus maximus), Fas activity was stimulated 436 
by dietary VO although the differences were not significant (56). It is unclear what 437 
exactly is responsible for the apparent discrepancy between these results. However, the 438 
increased expression of srebp1 in response to dietary VO, particularly notable in liver, 439 
suggested increased regulatory activity of Srebp1 towards potential target genes 440 
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including fas and thus increasing their transcription. The patterns of dietary regulation 441 
of srebp1 and fas share a similar shape in liver (modelled by quadratic functions) 442 
suggesting co-regulation. Their up-regulation in response to dietary VO indicated that 443 
de novo lipogenesis may contribute to increased lipid deposition, as suggested 444 
previously by Morais et al. (18) when studying diet/genotype interactions in Atlantic 445 
salmon.  446 
Beyond the anabolic processes described above, the impact of dietary VO was 447 
further evidenced in lipid catabolic processes such as β-oxidation. Generally, the 448 
expression of catabolic genes (pparα1 and cpt1α) in liver and, to some extent, in mid-449 
intestine, decreased with increasing dietary VO mid-intestine. The data were variable as 450 
illustrated by low R2 values, indicating that the diet was not the sole source of variation 451 
in the expression of these genes. The reduction in catabolic gene expression is coherent 452 
with the observed increased hepatic lipid levels associated with dietary VO. 453 
Furthermore, the results were consistent with previous studies in rats (57, 58) and Atlantic 454 
salmon (18) that revealed that dietary FO increased the expression of pparα and the 455 
activity of β-oxidation enzymes. In contrast, a recent study demonstrated expression of 456 
pparα1 and its target cpt1α were increased in liver of gilthead seabream fed diet 457 
containing both wild-type Camelina sativa oil (a low LC-PUFA diet) and containing 458 
genetically-modified camelina oil (containing n-3 LC-PUFA), although both these diets 459 
contained sufficient FM to satisfy EFA requirements (59). Dong et al. (60) have recently 460 
shown that pparα1 expression in response to VO was different in three species of fish. 461 
The authors observed, dietary VO increased expression of pparα1 and pparα2 in 462 
rainbow trout (Oncorhynchus mykiss) and decreased expression of pparα2 in Japanese 463 
seabass (Lateolabrax japonicus), but had no effect in livers of yellow croaker 464 
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(Larimichthys crocea). This finding complicates the regulation of lipid homeostasis but 465 
means that lipid catabolic processes can be regulated by a broad range of endogenous 466 
stimuli.  467 
In conclusion, the present study demonstrated that diets deficient in essential LC-468 
PUFA can cause reduction in growth rates alterations to lipid metabolism, fatty acid 469 
composition of liver and the regulation of genes involved in lipogenesis and catabolism. 470 
Despite the high variability in the expression of lipogenic genes the effect of their 471 
expression appears to be become measurable in D1-3 and this agrees with the analysis 472 
of the final weight and SGR data. Therefore, the alteration to the expression of the 473 
genes involved in lipogenesis and energy balance appear to be related to the fish growth 474 
performance. Therefore, D4-D6 appear to provide sufficient EFA and D1-D3 appear to 475 
be deficient. Despite the high energy (high lipid) diets used in the present study, 476 
expression of lipogenic genes such as fas involved in de novo biosynthesis was 477 
increased by dietary VO. In contrast, ppara1 and its target cpt1α were down-regulated 478 
and the expression was linear and therefore appeared to be modulated in a 479 
concentration-dependant manner. However, the expression of srebp1 and its gene 480 
targets was modelled by a curve, which was indicative of a threshold concentration at 481 
which gene expression was activated, although it is difficult to determine this point due 482 
to high variability between fish. Overall, the results reported in the present study were 483 
consistent with those reported in rats (61), that the LC-PUFA found in FO have a 484 
stimulating effect on β-oxidation and an inhibitory effect on de novo lipogenesis. These 485 
opposing biochemical activities would be expected to contribute towards the increased 486 
hepatic lipid observed in fish fed increasing VO in the present study and others 487 
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investigating EFA nutrition. These physiological effects of VO have direct relevance to 488 
decisions regarding sustainable and modern feed formulations for marine fish species. 489 
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Tables 674 
Table 1. Diet formulations and proximate analyses of the six experimental diets. 675 
DIET  
Ingredients (%) D1 D2 D3 D4 D5 D6 
Fishmeal  12.5 12.5 12.5 12.5 12.5 12.5 
Soya Protein Concentrate  21.9 21.9 21.9 21.9 21.9 21.9 
Rape seed meal 10.0 10.0 10.0 10.0 10.0 10.0 
Wheat Gluten 4.0 4.0 4.0 4.0 4.0 4.0 
Corn Gluten 25.0 25.0 25.0 25.0 25.0 25.0 
Wheat 7.1 7.1 7.1 7.1 7.1 7.1 
Aminoacids1  0.8 0.8 0.8 0.8 0.8 0.8 
Micro-ingredients2 3.1 3.2 3.2 3.3 3.5 3.9 
Yttrium 0.03 0.03 0.03 0.03 0.03 0.03 
OILS (%) 
      Fish Oil (SA) 0.0 1.8 2.6 4.4 8.0 14.9 
Rapeseed Oil 10.4 9.2 8.6 7.3 4.8 0.0 
Palm Oil 5.2 4.6 4.2 3.6 2.4 0.0 
       
PROXIMATE 
COMPOSITION 
(% of diet as fed) 
      Protein   41.8 43.0 42.9 41.7 42.4 42.5 
Lipid  22.2 21.7 21.7 21.5 21.8 20.8 
Ash  6.1 6.1 5.9 5.9 6.1 6.2 
Moisture  10.3 9.7 9.4 10.7 8.9 8.9 
Energy crude (MJ/kg)3 22.0 22.1 22.2 21.8 22.2 22.0 
1 Lysine and methionine 676 
2 Vitamin and mineral premix, monocalcium-phosphate (MCP), cholesterol, Emulthin 677 
G35, antioxidants  678 
3 Estimated by using the mean values of gross energy for proteins, lipids and 679 
carbohydrates 23.6, 39.5 and 17.2 kJ/g, respectively (15) 680 
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Table 2. Fatty acid composition of the experimental diets (D1-D6) given as percentage 682 
of total fatty acids. Note trace (<0.05) fatty acids are removed. Saturated fatty acids, 683 
SFA; monounsaturated fatty acids, MUFA; polyunsaturated fatty acids, PUFA. 684 
Fatty acid (%) D1 D2 D3 D4 D5 D6 
Lipid (%) 22.16 21.71 21.71 21.47 21.82 20.82 
14:0 0.55 1.07 1.47 2.10 3.34 5.73 
16:0 15.44 15.62 15.71 16.05 16.69 17.52 
18:0 2.53 2.62 2.67 2.80 3.04 3.43 
20:0 0.46 0.38 0.43 0.41 0.36 0.26 
22:0 0.23 0.23 0.22 0.21 0.19 0.16 
ΣSFA 19.35 20.04 20.64 21.70 23.75 27.22 
16:1n-7 0.51 1.12 1.48 2.20 3.65 6.71 
18:1n-9 47.13 43.91 41.89 37.57 29.37 12.38 
18:1n-7 2.47 2.55 2.58 2.69 2.77 2.99 
20:1n 0.93 0.97 0.98 1.04 1.11 1.29 
22:1n-11 0.08 0.14 0.19 0.28 0.43 0.75 
24:1n-9 0.14 0.17 0.19 0.23 0.29 0.47 
ΣMUFA 51.32 48.92 47.37 44.10 37.77 24.69 
18:2n-6 21.42 20.42 19.69 18.56 16.16 11.22 
18:3n-6 0.00 0.03 0.04 0.07 0.12 0.25 
20:2n-6 0.06 0.07 0.07 0.08 0.10 0.14 
20:4n-6 0.05 0.11 0.15 0.23 0.40 0.78 
22:5n-6 0.00 0.04 0.05 0.09 0.16 0.31 
Σ n-6 PUFA 21.52 20.67 20.01 19.03 17.01 12.90 
18:3n-3 6.05 5.69 5.52 5.03 3.99 1.76 
18:4n-3 0.08 0.30 0.44 0.70 1.23 2.40 
20:4n-3 0.03 0.08 0.11 0.18 0.32 0.62 
20:5n-3 0.70 1.96 2.73 4.32 7.48 14.34 
22:5n-3 0.11 0.26 0.35 0.53 0.91 1.71 
22:6n-3 0.63 1.47 1.98 3.06 5.23 9.89 
Σ n-3 PUFA 7.61 9.76 11.13 13.83 19.16 30.77 
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Table 3. Primer sequences used for gene expression analysis by quantitative reverse-686 
transcriptase PCR. Amplicon sizes (base pair) and GenBank accession numbers also are 687 
provided. 688 
Transcript Sequence (5'-3') Amplicon(bp) Accession no 
fads2 F:GCAGGCGGAGAGCGACGGTCTGTTCC 72 AY055749 
 
R:AGCAGGATGTGACCCAGGTGGAGGCAGAAG 
 elovl5 F:CCTCCTGGTGCTCTACAAT 112 AY660879 
 
R:GTGAGTGTCCTGGCAGTA 
  cpt1α F:GTGCCTTCGTTCGTTCCATGATC 82 JQ308822 
 
R:TGATGCTTATCTGCTGCCTGTTTG 
  srebp1 F:AGGGCTGACCACAACGTCTCCTCTCC 77 JQ277709 
 
R:GCTGTACGTGGGATGTGATGGTTTGGG 
  pparα1 F:TCTCTTCAGCCCACCATCCC 116 AY590299 
 
R:ATCCCAGCGTGTCGTCTCC 
  fabp1  F:CATGAAGGCGATTGGTCTCC 165 KF857311  
 
R:GTCTCCAAGTCTGCCTCCTT 
  srebp2  F:GCTCACAAGCAAAATGGCCT 240 AM970922.1 
 
R:CAAAACTGCTCCCTTCCCCA 
  fas F:TGCCATTGCCATAGCACTCA 172 JQ277708.1 
 
R:ACCTTTGCCCTTTGTGTGGA 
  β-act F:TCCTGCGGAATCCATGAGA 50 X89920 
 
R: GACGTCGCACTTCATGATGCT 
  ef1α F:ACGTGTCCGTCAAGGAAATC 109 AF184170 
 
R:GGGTGGTTCAGGATGATGAC 
  tuba1α F:ATCACCAATGCCTGCTTCGA 214 AY326430.1 
 
R:CTGTGGGAGGCTGGTAGTTG 
  rplp0 F:GAACACTGGTCTGGGTCCTG 159 AY550965.1 
 
R:TTCAGCATGTTGAGGAGCGT 
   689 
 690 
 691 
 692 
 693 
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Table 4. Final weights and specific growth rates of Sparus aurata after 18 weeks 694 
feeding on diets D1-6. Superscript letters indicate significant between group differences 695 
by ANOVA.  696 
Diet Weight (g) SD SGR* SD 
D1 198.6 c ± 1.3 1.64 d ± 0.01 
D2 219.4 b ± 6.6 1.72 c ± 0.02 
D3 224.8 b ± 5.0 1.75 cb ± 0.01 
D4 241.3 a ± 3.1 1.78 ab ± 0.00 
D5 245.0 a ± 4.0 1.81 a ± 0.01 
D6 248.3 a ± 1.5 1.81 a ± 0.01 
ANOVA P < 0.001 		 P < 0.001 
*SGR = (ln Final weight – ln Initial weight)/ days x 100  697 
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Figures 698 
 699 
Figure 1. Graphical representation of principal components analysis (PCA) of fatty acid 700 
profiles from liver (n=54) of fish fed experimental diets (D1 - D6). The two panels are 701 
complimentary to one another. Panel A is a biplot of the first two principal components 702 
(PC1 and PC2) of gilthead seabream liver fatty acid profiles. The fatty acid profiles of 703 
fish consuming diets D5 and D6 formed succinct groups to the right of the plot and they 704 
were well defined by PC1. The fatty acid profiles of fish consuming diets D1 - D4 were 705 
negatively correlated to PC1 and there was considerable overlap (variability) between 706 
the dietary treatments. PC2 accounted for 15.3 % of the total variance and was 707 
important to distinguish individual liver fatty acid profiles of fish consuming diets D1 - 708 
D3. Panel B shows all the variables (fatty acids) used to construct the principal 709 
components. The circle in this plot is the correlation circle, the stronger the correlation 710 
of a fatty acid to PC1 and, or PC2 the closer its arrowhead to the circle. Arrowheads that 711 
do not approach the circle are not well represented by PC1 and PC2 (e.g. 22:0). The 712 
arrows indicate how the fatty acids contributed to the formation of PC1 and PC2 and 713 
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thus the formation of Panel A. Several points can be made to describe the data, the fatty 714 
acids derived from fish oil (e.g. 22:6n-3) were strongly correlated to PC1, the main fatty 715 
acids from vegetable oil (e.g. 18:1n-9) were negatively correlated to PC1. Several fatty 716 
acids were best explained by a combination of PC1 and PC2, including 18:2n-9 and 717 
20:2n-9, and it can be said that these fatty acids are important to distinguish liver fatty 718 
acid profiles from fish consuming diets D1 - D4. D1 = ○ ; D2 = △ ; D3 =  	; D4 = + ;  719 
D5 = ⊠ ; D6 =   720 
  721 
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 722 
 723 
Figure 2. Graphical representation of principal components analysis (PCA) of fatty acid 724 
profiles from mid-intestine (n=54) of fish fed experimental diets (D1 - D6). The two 725 
panels are complimentary to one another. Panel A is a biplot of the first two principal 726 
components (PC1 and PC2) of seabream mid-intestine fatty acid profiles. The fatty acid 727 
profiles of fish consuming diets D5 and D6 formed succinct groups to the right of the 728 
plot. The fatty acid profiles of fish consuming diets D1 – D3 were negatively correlated 729 
to PC1 and there was considerable overlap in the points. PC2 separated the fatty acid 730 
profiles vertically and explained 15.5 % of the variance, two outliers appeared in D3 731 
and these samples contained unusually high levels 20:0 and 22:0 and, other than these 732 
samples, the variance was quite evenly distributed amongst the diets when compared to 733 
liver. Panel B shows all the variables (fatty acids) used to construct the principal 734 
components. The circle in this plot is the correlation circle, the stronger the correlation 735 
of a fatty acid to PC1 and, or PC2 the closer its arrowhead to the circle. Arrowheads that 736 
do not approach the circle were not well represented by PC1 and PC2 (e.g. 16:1n-9). 737 
The arrows indicate how the fatty acids contributed to the formation of PC1 and PC2 738 
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and thus the formation of plot A. D1 = ○ ; D2 = △ ; D3 =  	; D4 = + ;  D5 = ⊠ ; D6 = 739 
 . 740 
 741 
Figure 3. Levels of n-3 long-chain (≥ C20) polyunsaturated fatty acids (LC-PUFA) in 742 
gilthead seabream liver (A) and mid-intestine (B) against the dietary levels of n-3 LC-743 
PUFA. Note the natural logarithm (ln) transformation applied to the data in panel A 744 
indicating that in liver this relationship was not linear. Both models were linear ordinary 745 
least squares fits with the standard error shaded in grey (n=54). Diet 1 = ○ ; Diet 2 = △ ; 746 
Diet 3 =  	; Diet 4 = + ;  Diet 5 = ⊠ ; Diet 6 =   747 
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 748 
Figure 4. Levels of monounsaturated fatty acids (MUFA) in gilthead seabream liver (A) 749 
and mid-intestine (B) against the dietary levels of MUFA. Both are quadratic ordinary 750 
least squares fits with the standard error shaded in grey (n=54). Diet 1 = ○ ; Diet 2 = △ ; 751 
Diet 3 =  	; Diet 4 = + ;  Diet 5 = ⊠ ; Diet 6 =   752 
  753 
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 754 
 755 
Figure 5. Levels of 18:2n-90.25, which is not present in the diets, in gilthead seabream 756 
liver against dietary vegetable oil (A), and the level of fads2 expression correlated (r = 757 
0.64; P < 0.001) with the levels of 18:2n-90.25 in liver (B). The model applied in A is a 758 
quadratic ordinary least squares fit with the standard error shaded in grey (n=54). Note 759 
the transformation (x0.25) applied to the 18:2n-9 data. Diet 1 = ○ ; Diet 2 = △ ; Diet 3 = 760 
 	; Diet 4 = + ; Diet 5 = ⊠ ; Diet 6 =   761 
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Figure 6. Hepatic gene expression of ppara1 (A), cpt1a (B) and fabp1 (C) against 763 
dietary vegetable oil. Data are log2 (expression ratios) normalised to four reference 764 
genes and then to the calibrator sample. Fitted lines are linear functions with the 765 
standard error highlighted in grey (n=54). Diet 1 = ○ ; Diet 2 = △ ; Diet 3 =  	; Diet 4 766 
= + ;  Diet 5 = ⊠ ; Diet 6 =   767 
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Figure 7. Hepatic gene expression of srebp1 (A), fas (B) and fads2 (C) against dietary 769 
vegetable oil. Data are log2 (expression ratio) normalised to four reference genes and 770 
then to the calibrator sample. Fitted lines are second order quadratic functions with the 771 
standard error highlighted in grey (n=54). The similarity between the responses is 772 
striking. Diet 1 = ○ ; Diet 2 = △ ; Diet 3 =  	; Diet 4 = + ;  Diet 5 = ⊠ ; Diet 6 =   773 
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Figure 8. Mid-intestine gene expression of srebp1 (A), srebp2 (B) and elovl5 (C) 775 
against dietary vegetable oil. Data are log2 (expression ratio) normalised to four 776 
reference genes and then to the calibrator sample. Fitted lines are linear fits for srebp1 777 
and elovl5 and a second order quadratic function is fitted to srebp2. The model standard 778 
errors are highlighted in grey (n=54). Diet 1 = ○ ; Diet 2 = △ ; Diet 3 =  	; Diet 4 = + ;  779 
Diet 5 = ⊠ ; Diet 6 =   780 
